Vinpocetine (CAS 42971-09-5) is a high-purity cerebral metabolic enhancer API, a semisynthetic indole alkaloid derived from the periwinkle plant Vinca minor. With a precise molecular structure, it acts by inhibiting phosphodiesterase (PDE) and promoting prostaglandin synthesis, thereby improving cerebral blood flow, oxygen utilization, and glucose metabolism in the brain.
Produced under strict GMP standards, this API ensures consistent purity (≥99%) and stability, making it ideal for pharmaceutical formulation. It is widely applied in the development of drugs for the treatment of cerebrovascular diseases, cognitive impairment, and senile dementia, catering to the needs of pharmaceutical manufacturers and research institutions in the field of neurology and geriatrics.
Its unique ability to enhance cerebral metabolism and protect neurons makes it a valuable tool in the management of neurological disorders. Vinpocetine delivers reliable therapeutic benefits with a favorable safety profile, supporting the development of effective treatments for brain function disorders.
